| RS1555850590 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1555850609 |
SALL4
|
Health Risk |
Pathogenic |
— |
| RS1555850842 |
KCNQ2
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, KCNQ2-related disorder |
| RS1555850868 |
KCNQ2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, KCNQ2-related disorder |
| RS1555850961 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS1555851216 |
ZNF335
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555851513 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1555851516 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1555853524 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1555853549 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1555853593 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1555853970 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS1555853971 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1555853977 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1555853999 |
COL18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1555854643 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1555855228 |
TNNT1
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS1555859144 |
ATP1A3
|
Health Risk |
Pathogenic |
— |
| RS1555859150 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS1555859157 |
ATP1A3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Dystonia 12 |
| RS1555859304 |
TNNT1
|
Health Risk |
Pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS1555859571 |
ATP1A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS1555859593 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555859876 |
TNNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 5, Inborn genetic diseases |
| RS1555860555 |
COL18A1
|
Health Risk |
Pathogenic |
Knobloch syndrome, Knobloch syndrome |
| RS1555860693 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1555860861 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS1555861946 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Inborn genetic diseases |
| RS1555862098 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alternating hemiplegia of childhood 2, Alternating hemiplegia of childhood 2 |
| RS1555863145 |
SLC12A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS1555863593 |
SLC12A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS1555863623 |
ATP1A3
|
Health Risk |
Pathogenic |
Alternating hemiplegia of childhood 2, Alternating hemiplegia of childhood 2 |
| RS1555863693 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Developmental and epileptic encephalopathy 99 |
| RS1555863715 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1555865385 |
ATP1A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Dystonia 12, ATP1A3-associated neurological disorder |
| RS1555865401 |
ATP1A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Juvenile onset psychosis, Dystonia 12 |
| RS1555866356 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS1555868362 |
GNAS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555868402 |
SLC12A5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS1555869700 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1555869758 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Early-infantile DEE |
| RS1555869796 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1555869803 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1555869934 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS1555869958 |
CBS
|
Health Risk |
Pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS1555869979 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS1555870346 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1555870470 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1555870506 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1555870554 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1555870809 |
COL18A1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Knobloch syndrome |
| RS1555871095 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS1555871188 |
CBS
|
Health Risk |
Pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS1555871390 |
COL6A2
|
Health Risk |
Pathogenic |
— |
| RS1555871777 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555871832 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1555871853 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1555871862 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1555871902 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555871915 |
KCNQ2
|
Health Risk |
Likely pathogenic |
KCNQ2-related disorder, KCNQ2-related disorder |
| RS1555871928 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555872060 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555872143 |
COL6A2
|
Health Risk |
Pathogenic |
— |
| RS1555872200 |
COL6A2
|
Health Risk |
Pathogenic |
— |
| RS1555872272 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555872755 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555872787 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS1555872819 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1555872873 |
COL6A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1555872879 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555872965 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS1555872988 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555872997 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555873084 |
COL6A2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Bethlem myopathy 1A |
| RS1555873087 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555873118 |
AIRE
|
Health Risk |
Pathogenic |
— |
| RS1555873248 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555873353 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1555873356 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1B |
| RS1555873358 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1555873507 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Abnormality of the musculature |
| RS1555873508 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1555873650 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1555873656 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1555873665 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, Early-infantile DEE |
| RS1555873683 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1555873698 |
COL6A2
|
Health Risk |
Likely pathogenic |
— |
| RS1555873790 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Seizure |
| RS1555873813 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1555873823 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1555873925 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS1555873939 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1555873981 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1555873982 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Neonatal encephalopathy, Neonatal encephalopathy |
| RS1555873985 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial neonatal |
| RS1555874020 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1555874121 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS1555874263 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS1555874527 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS1555874538 |
COL18A1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |